SEC Form 4 · accession 0000899243-18-031346
Q32 Bio Inc. · QTTB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert Seymour
Officer — Chief Scientific Officer
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001661998
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock optionF1 | $24.28 | Dec 14, 2018 | A | 74,000 | A | — | Dec 14, 2028 | Common Stock | 74,000 | 74,000 | D |
Explanation of responses
- F1The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2019.